Parkway Life Real Estate Investment Trust has delivered a 31.6% share price gain over the past three years, helped by steady recent returns and fresh expansion moves in Europe. That performance puts a spotlight on a simple question for investors who focus on fundamentals: whether the current unit price is justified by the cash flows the REIT can generate.
-
Over the last three years, Parkway Life Real Estate Investment Trust has returned 31.6%, which puts recent unitholders in profit and raises the bar for what its future cash generation needs to support.
-
The agreed €38.8 million purchase of three nursing homes in France, funded with debt and backed by 12 year leases, can reshape expectations around Parkway Life Real Estate Investment Trust's rental visibility, funding costs and timing of cash inflows.
-
Prefer to judge Parkway Life Real Estate Investment Trust on earnings? See why Parkway Life Real Estate Investment Trust's 15.9x P/E tells a different valuation story .
The issue now is whether Parkway Life Real Estate Investment Trust's present market price fairly reflects the cash flows implied by its Discounted Cash Flow (DCF) intrinsic value estimate.
If you are weighing Parkway Life Real Estate Investment Trust against other valuation ideas focused on its cash flows, it can help to compare it with a curated list of 196 high quality undervalued stocks .
Is Parkway Life Real Estate Investment Trust Still Cheap on Cash Flow?
The Discounted Cash Flow (DCF) model here is built around Parkway Life Real Estate Investment Trust's ability to keep generating cash for unitholders. Latest twelve month free cash flow sits at about SGD117.5 million, with the model assuming this pool of cash edges higher over time rather than swinging sharply up or down.
Projected free cash flows in the late 2020s are set a little above current levels. This presents Parkway Life Real Estate Investment Trust as a relatively mature REIT with steady, modestly growing cash generation rather than a high growth story. The recent €38.8 million purchase of three French nursing homes, funded with debt and backed by 12 year leases, fits that picture because it adds contracted rental income that a DCF framework can treat as visible future cash flows even as leverage rises slightly.
When those forecast cash flows are discounted back and compared with today's traded price of SGD4.03, the DCF projections put Parkway Life Real Estate Investment Trust's estimated intrinsic value meaningfully above the current share price. Find out what Parkway Life Real Estate Investment Trust could be worth using our Discounted Cash Flow (DCF) estimate .
The Parkway Life Real Estate Investment Trust Narrative: What Would Justify Today's Price?
Narratives for Parkway Life Real Estate Investment Trust pick up where the DCF puzzle leaves off and describe what path for future growth, profitability and earnings would need to hold for the unit price to end up meaningfully higher or lower than it is today. They sit on Simply Wall St's Community page. Each one sets out Parkway Life Real Estate Investment Trust's fair value as a thesis about the business that you can track over time rather than a single static estimate.
A written, number driven Narrative on Parkway Life Real Estate Investment Trust helps pin down the assumptions behind its cash flow profile and lets you test over time whether the actual figures line up with that view. With the planned €38.8 million French nursing home acquisition and modestly higher leverage ahead, a clear framework also gives you a way to track whether that deal delivers the rental resilience and funding balance you expect.
Share your own Narrative for Parkway Life Real Estate Investment Trust and set out the assumptions behind your valuation.
One more Parkway Life Real Estate Investment Trust check that belongs beside the valuation work
Price and cash flows only tell part of the story, because Parkway Life Real Estate Investment Trust also has specific risk checks that our research has flagged for closer inspection. Take a closer look at 3 warning signs (2 major) before settling on a valuation.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include C2PU.SI .
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
